Please login to the form below

Not currently logged in
Email:
Password:

FDA approves Teva's Alzheimer's drug

The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept

The US Food and Drug Administration (FDA) has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept (donepezil).

Teva said that it has already begun shipping the product, in 5mg and 10mg tablets.

Aricept has been the market leader among drugs that alleviate symptoms of Alzheimer's disease, such as memory problems, confusion and aggression.

Annual sales of the drug in the US are believed to be $2.3 bn.

Meanwhile Teva has declined to comment on media reports that its president and chief executive Shlomo Yanai flew to India several days ago to discuss potential collaborations with Indian pharmaceutical companies.

2nd June 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....